More Life Sciences news. A small operation, but has potential, and multiply this scenario 100 times per year, and things look good for Philadelphia.
French gene therapy company SparingVision establishes U.S. headquarters in Philadelphia
https://www.bizjournals.com/philadel...Pos=0#cxrecs_s
"A French genomics medicines company focused on developing vision-saving treatments for retinal diseases has established its U.S. headquarters in Philadelphia.
Paris-based SparingVision has opened an office in Center City at Three Logan Square."
""Philadelphia is becoming a major hub for cell and gene therapy, so this was a natural place to put our U.S. headquarters," said Dan Chung, SparingVision's chief medical officer."
"SparingVision, founded in 2016, has 25 employees overall and opened its Philadelphia office this week with two people. Chung said he is actively recruiting for people with medical affairs and clinical development positions. "We expect to be at eight to 10 people by the end of the year," he said. "We'll have more people coming in the second quarter.""